Nanoparticles overcome adaptive immune resistance and enhance immunotherapy via targeting tumor microenvironment in lung cancer

• 主要な著者: Xin Zhang (著者), Xuemei Wang (著者), Lijian Hou (著者), Zheng Xu (著者), Yu'e Liu (著者), Xueju Wang (著者)
• フォーマット: 図書
• 出版事項: Frontiers Media S.A., 2023-03-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

Lung cancer is one of the common malignant cancers worldwide. Immune checkpoint inhibitor (ICI) therapy has improved survival of lung cancer patients. However, ICI therapy leads to adaptive immune resistance and displays resistance to PD-1/PD-L1 blockade in lung cancer, leading to less immune respon...